Soliton, Inc. (NASDAQ:SOLY) is reporting second quarter earnings results on Tuesday 11th August 2020, before market open.
The consensus estimates from Thomson Reuters are loss of $ 0.19 per share.
For the full year, analysts predict loss of $ 0.77 per share.
Previous Quarter Performance
Soliton, Inc. outlined loss for the first quarter of $ 0.19 per share, from the revenue of . The quarterly revenues compared with the same quarter last year. According to street consensus, loss of $ 0.25 was expected per share The bottom line results beat street analysts by $ 0.06 or 24.00 percent, at the same time, top line results analysts by $ 0.32 million or .
Stock Performance
According to the previous trading day, closing price of SOLY was $ 7.02, representing a 12.32 % increase from the 52 week low of $ 6.25 and a 54.71 % decrease over the 52 week high of $ 15.50.
The company has a market capital of $ 148.75 million and is part of the Healthcare sector and Medical Devices industry.
Recent Analyst recommendations
- On 15th July 2020, initiated by Cantor Fitzgerald at Overweight rating, with $ 12.00 target price.
Conference Call
Soliton, Inc. will be hosting a conference call at 8:30 AM eastern time on 11th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.soliton.com
Soliton, Inc., an early stage medical device company, focuses on developing and commercializing products using a proprietary rapid acoustic pulse technology platform. It offers a device for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.
